Published in BMJ on November 26, 1988
The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut (2007) 2.10
Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review. Thorax (2001) 1.71
Bronchial asthma and acid reflux into the distal and proximal oesophagus. Arch Dis Child (1990) 1.01
Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study. Postgrad Med J (1994) 0.97
Temporal associations between coughing or wheezing and acid reflux in asthmatics. Gut (2001) 0.96
Gastroesophageal reflux disease in asthma: effects of medical and surgical antireflux therapy on asthma control. Ann Surg (2000) 0.95
Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux. World J Gastroenterol (2007) 0.87
Gastro-oesophageal reflux and bronchial asthma: current status and future directions. Postgrad Med J (2004) 0.85
Tracheal microaspiration in adult cystic fibrosis. J R Soc Med (1998) 0.80
Nocturnal asthma. Thorax (1993) 0.76
The association between reflux esophagitis and airway hyper-reactivity in patients with gastro-esophageal reflux. J Res Med Sci (2013) 0.75
Insight Into the Relationship Between Gastroesophageal Reflux Disease and Asthma. Gastroenterol Hepatol (N Y) (2014) 0.75
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Correlation between manometric and pH tests for gastro-oesophageal reflux. Gut (1977) 1.80
The role of the vague nerve in airway narrowing caused by intraesophageal hydrochloric acid provocation and esophageal distention. Ann Allergy (1981) 1.46
Relationship between asthma and gastro-oesophageal reflux. Thorax (1981) 1.45
Limitations of 24-hour intraesophageal pH monitoring in the hospital setting. Gastroenterology (1985) 1.34
Gastro-oesophageal reflux and childhood asthma: the acid test. Thorax (1985) 1.29
Treatment of reflux oesophagitis with ranitidine. Gut (1983) 1.29
The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma. Ann Allergy (1982) 1.10
Gastroesophageal reflux in steroid-dependent asthmatic youths. Pediatrics (1979) 1.10
Esophageal reflux as trigger in asthma. N Y State J Med (1966) 0.94
Quantitative gastroesophageal reflux and pulmonary function in asthmatic children and normal adults receiving placebo, theophylline, and metaproterenol sulfate therapy. J Allergy Clin Immunol (1984) 0.91
The prevalence of asymptomatic gastroesophageal reflux in bronchial asthma and in non-asthmatic individuals. Eur J Respir Dis (1983) 0.90
Gastro-oesophageal reflux and night-time asthma. Lancet (1985) 0.88
Gastroesophageal reflux during sleep in asthmatic patients. J Pediatr (1983) 0.87
Radionuclide assessment in nocturnal asthma. Clin Nucl Med (1982) 0.85
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging (2001) 4.54
Human immunodeficiency virus integration in a cell-free system. J Virol (1990) 4.48
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology (2012) 4.09
Genetic control of natural variation in Arabidopsis glucosinolate accumulation. Plant Physiol (2001) 4.07
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group. Gastroenterology (1998) 3.90
Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology (2006) 3.71
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology (2003) 3.35
Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
An evaluation of the mini-Wright peak flow meter. Thorax (1979) 2.91
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Bias inherent in retrospective waiting-time studies: experience from a vascular surgery waiting list. CMAJ (2000) 2.74
Social resources and cognitive decline in a population of older African Americans and whites. Neurology (2004) 2.66
Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology (2003) 2.60
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Change in body mass index and risk of incident Alzheimer disease. Neurology (2005) 2.48
Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology (2006) 2.48
Further evidence for small-bodied hominins from the Late Pleistocene of Flores, Indonesia. Nature (2005) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology (1987) 2.46
An extremely luminous X-ray outburst at the birth of a supernova. Nature (2008) 2.41
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut (1987) 2.40
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology (2003) 2.32
Parkinsonian signs in subjects with mild cognitive impairment. Neurology (2005) 2.30
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging (2004) 2.29
Work-related respiratory disease in employees leaving an electronics factory. Thorax (1979) 2.29
New clinical sign for orthostatic tremor. Lancet (1995) 2.25
Ocular fireworks injuries and blindness. An analysis of 154 cases and a three-state survey comparing the effectiveness of model law regulation. Ophthalmology (1982) 2.25
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett (2000) 2.22
Gastric cancer detection in gastric ulcer disease. Gut (1980) 2.20
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
Bovine spongiform encephalopathy [corrected] Creutzfeldt-Jakob disease. BMJ (1996) 2.15
Effects of temperature on Vitalograph spirometer readings. Thorax (1983) 2.13
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10
A randomized clinical trial of anticaries therapies targeted according to risk assessment (caries management by risk assessment). Caries Res (2012) 2.08
Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol (1986) 2.06
Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med (1986) 2.06
Supervised harvesting of expression trees. Genome Biol (2001) 2.02
Vasculitis with alclofenac therapy. Br Med J (1974) 2.02
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Estimating cancer risk in relation to tritium exposure from routine operation of a nuclear-generating station in Pickering, Ontario. Chronic Dis Inj Can (2013) 1.97
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology (2008) 1.97
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Chiropractic care of children with nocturnal enuresis: a prospective outcome study. J Manipulative Physiol Ther (1991) 1.85
Assessment of aggression in psychiatric admissions: semistructured interview and case note survey. BMJ (2000) 1.85
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
Typing prion isoforms. Nature (1997) 1.82
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A (1999) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population. Ann Rheum Dis (1991) 1.79
Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (2000) 1.77
Occupational asthma in an electronics factory: a case control study to evaluate aetiological factors. Thorax (1979) 1.77
Kofi Annan describes new health fund for developing countries. BMJ (2001) 1.76
Ionophore toxicity in turkey breeders. Avian Dis (1983) 1.76
Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med (1985) 1.75
Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord (1998) 1.74
Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol (1989) 1.74
A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology (2003) 1.71
A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology (1994) 1.70
Nonoperative management of tracheal laceration during endotracheal intubation. Ann Thorac Surg (1997) 1.69
Improvement of stiff-man syndrome with vigabatrin. Neurology (1997) 1.68
Cancer registries fear imminent collapse. BMJ (2000) 1.68
Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science (1987) 1.67
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
Illusory perceptions of space and time preserve cross-saccadic perceptual continuity. Nature (2001) 1.64
Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry (1990) 1.63
[Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)]. Rev Neurol (Paris) (1978) 1.61
Updating the Read Codes: user-interactive maintenance of a dynamic clinical vocabulary. J Am Med Inform Assoc (1997) 1.60
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet (1994) 1.59
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. Br J Clin Pharmacol (1978) 1.59
The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol Cell Biol (1991) 1.59
Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease. Neurology (2010) 1.58
Epidemiology of injury in people with Alzheimer's disease. J Am Geriatr Soc (1995) 1.58
Associations of vegetable and fruit consumption with age-related cognitive change. Neurology (2006) 1.57
Muscle force is generated by myosin heads stereospecifically attached to actin. Nature (1997) 1.56
Diabetes mellitus, dementia, and cognitive function in older persons. J Nutr Health Aging (2006) 1.56
Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet (1991) 1.56
Body mass index in older persons is associated with Alzheimer disease pathology. Neurology (2006) 1.55